PRELUDE CAPITAL MANAGEMENT, LLC - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 212 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$96,000
+37.1%
11,600
+12.6%
0.00%0.0%
Q4 2020$70,000
-84.2%
10,300
-74.1%
0.00%
-90.5%
Q3 2020$443,000
+41.1%
39,800
-20.6%
0.02%
+23.5%
Q2 2020$314,000
+554.2%
50,100
+92.7%
0.02%
+466.7%
Q1 2020$48,000
-4.0%
26,000
+168.2%
0.00%
-25.0%
Q1 2018$50,000
+35.1%
9,6950.0%0.00%
+33.3%
Q4 2017$37,0009,6950.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Oaktree Fund Advisors, LLC 66,000$503,00048.93%
SABBY MANAGEMENT, LLC 1,698,107$12,957,0001.75%
EMFO, LLC 233,008$1,778,0001.57%
swisspartners Ltd. 110,000$839,0000.65%
HERITAGE WEALTH MANAGEMENT, LLC 150,000$1,145,0000.41%
Donald L. Hagan, LLC 42,929$328,0000.19%
COLLECTIVE FAMILY OFFICE LLC 44,203$337,0000.14%
Spectrum Wealth Advisory Group, LLC 18,093$138,0000.14%
NEXPOINT ASSET MANAGEMENT, L.P. 100,000$763,0000.13%
Cormorant Asset Management, LP 400,000$3,052,0000.12%
View complete list of SORRENTO THERAPEUTICS INC shareholders